Nonfatal myocardial infarction is, by itself, an inappropriate end point in clinical trials in cardiology

J. L. Fleiss, J. T. Bigger, M. McDermott, J. P. Miller, T. Moon, A. J. Moss, D. Oakes, L. M. Rolnitzky, T. M. Therneau

Research output: Contribution to journal › Editorial › peer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'Nonfatal myocardial infarction is, by itself, an inappropriate end point in clinical trials in cardiology'. Together they form a unique fingerprint.